John Assaro
About John Assaro
John Assaro serves as the Associate Vice President of US Commercial at ArisGlobal, a position he has held since 2022. He has extensive experience in strategic account management and business development across several leading technology and pharmaceutical companies.
Work at ArisGlobal
John Assaro has been serving as the Associate Vice President - US Commercial at ArisGlobal since 2022. In this role, he plays a significant part in supporting mission-critical tasks throughout the drug development process for the company's clients. His experience at ArisGlobal includes a previous position as Senior Account Executive from 2006 to 2009. Assaro has contributed to maintaining long-term relationships with key clients, including government health authorities such as the FDA, Health Canada, and the NMPA.
Previous Experience
Before joining ArisGlobal, John Assaro held various positions in the technology and life sciences sectors. He worked as a Strategic Account Executive at Tact.ai for six months in 2018 and at Madaket Health for one year from 2018 to 2019. His tenure at Salesforce included roles as Strategic Account Executive from 2013 to 2016 and Strategic Account Executive - Life Sciences/Health Care from 2016 to 2018. He also worked at Oracle as a Technical Sales Representative for one month in 2013 and served as Enterprise Account Manager - Life Sciences at EMC from 2011 to 2013.
Education and Expertise
John Assaro studied Electrical Engineering Technology at Mohawk Valley Community College, earning an Associate of Applied Science degree from 1981 to 1983. He furthered his education at the Rochester Institute of Technology, where he studied Business Administration and Management, General, and achieved a Bachelor of Applied Science (BASc) from 1983 to 1987. His educational background supports his extensive experience in technology solutions and business development within the life sciences sector.
Achievements in Life Sciences
Throughout his career, John Assaro has been instrumental in providing technology solutions to 40 of the top 50 biopharmaceutical companies and four of the top five pharmaceutical companies. His expertise in maintaining client relationships and understanding the complexities of the drug development process has positioned him as a key player in the life sciences industry.